Risk factors of cirrhosis combined with sarcopenia and their impact on clinical outcomes
10.3760/cma.j.issn.1007-3418.2020.01.013
- VernacularTitle: 肝硬化合并肌肉减少症的危险因素及其对临床结局的影响
- Author:
Huijuan XIAO
1
,
2
;
Qing YE
3
;
Ming ZHANG
1
,
2
;
Yuemei QI
1
,
2
;
Tao HAN
1
,
4
,
5
,
6
;
Xin WANG
1
,
2
Author Information
1. Third Centre Clinical College, Tianjin Medical University, Tianjin 300170, China
2. Department of Nutrition, Third Central Hospital of Tianjin Affiliated to Nankai University, Tianjin 300170, China
3. Department of Gastroenterology and Hepatology, Third Central Hospital of Tianjin Affiliated to Nankai University, Tianjin 300170, China
4. Department of Gastroenterology and Hepatology, Third Central Hospital of Tianjin Affiliated to Nankai University, Tianjin 300170, China
5. Tianjin Institute of Hepatobiliary Disease, Tianjin, 300170, China
6. Tianjin Key Laboratory of Artificial Cell, Tianjin, 300170, China
- Publication Type:Journal Article
- Keywords:
Liver cirrhosis;
Sarcopenia;
Appendicular skeletal muscle mass index
- From:
Chinese Journal of Hepatology
2020;28(1):53-57
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the occurrence of sarcopenia in patients with liver cirrhosis, and to explore their risk factors and impact on clinical outcomes.
Methods:199 hospitalized cases with liver cirrhosis were collected for nutritional risk screening, anthropometric measurement and blood biochemical examination. The body composition analysis was measured based on the skeletal muscle content of the four limbs to calculate the appendicular skeletal muscle mass index (ASMI). Patients were divided into sarcopenia and non-sarcopenia group and the relevant indexes of both groups were compared to screen for factors affecting the occurrence of sarcopenia. During the follow-up of 48 months, the survival and complications of the both groups were compared. Statistical analysis was performed using t-test, χ2 test and logistic regression analysis in terms of different data.
Results:The incidence of sarcopenia in cirrhosis was 36.7%, with the highest prevalence in patients with recurrent hepatic encephalopathy (62.5%), followed by patients with abdominal ascites / pleural effusion (37.6%). The incidence of sarcopenia was significantly higher in those with nutritional risk than in those without nutritional risk (P < 0.05). However, even among those without nutritional risk, 14.8% had combined sarcopenia. The body mass index (BMI), upper arm muscle circumference (AMC), and body cell mass (BCM) of the sarcopenia group were lower than those of the non-sarcopenia group (P < 0.05), and the edema index (ECW/TBW) was higher than the latter (P < 0.05). Multivariate analysis showed that age, gender, BMI, and complications of hepatic encephalopathy were the main influencing factors of cirrhosis combined with sarcopenia (P < 0.05). During the follow-up period, the sarcopenia group had a higher mortality rate than non-sarcopenia goup (P < 0.05), and the incidence of recurrent abdominal ascites/pleural effusion, hepatic encephalopathy, and infection was also significantly elevated (P < 0.05).
Conclusion:Sarcopenia is one of the manifestations of malnutrition in patients with liver cirrhosis, which increases the risk of mortality and other complications, and has adverse impact on the clinical outcome. Additionally, older age, male sex, low BMI and recurrent hepatic encephalopathy has higher risk for developing sarcopenia.
